Newsroom · Sioux Falls

Medicare Cancer & Chemotherapy Coverage in Sioux Falls 2026: What Part B, Part D, and Your Plan Actually Pay

IV chemo hits Part B; oral chemo hits Part D — and the new $2,100 cap makes that distinction matter more than ever for Minnehaha County's ~3,163 beneficiaries with a cancer diagnosis.

Big Sioux Benefits Data Desk

Published July 13, 2026 · 10 min read · Sourced from CMS.gov & CDC

Medicare covers chemotherapy — but which part of Medicare pays, and how much you owe, depends entirely on how the drug is delivered. IV chemo administered in a clinical setting is a Part B medical benefit with open-ended cost exposure. Oral chemo you take at home is a Part D drug benefit now backstopped by the new $2,100 annual cap. Understanding that split is the foundation of cancer-aware Medicare planning in 2026.

Every figure below comes from public federal data: the CDC PLACES 2023 county health file, the CMS 2025 Medicare Parts A & B cost-sharing fact sheet, the CMS PY2026 plan landscape, and CMS Hospital Compare. No invented numbers.

The cancer burden in Minnehaha County

Cancer isn't a hypothetical risk for Sioux Falls' Medicare population — it's a current reality for thousands of local beneficiaries. CDC PLACES 2023 model-based data shows 8% of Minnehaha County adults have a diagnosed non-skin cancer, which translates to roughly 3,163 of the county's 39,532 Medicare enrollees. And cancer rarely travels alone — many patients simultaneously manage the chronic conditions that compound care complexity:

Source: CDC PLACES: Local Data for Better Health, County 2023 — Minnehaha County adults, model-based prevalence (2023).

The overlap matters: diabetes (10.0%) and coronary heart disease (5.5%) can complicate chemotherapy tolerability, affect drug interactions, and drive additional specialist visits — all running through either Part B or Part D cost-sharing. Depression (22.3%) is both a comorbidity and a treatment side effect. For these patients, choosing the wrong Medicare structure can mean thousands of dollars in unnecessary exposure.

How Medicare splits chemotherapy: Part B vs. Part D

The single most misunderstood piece of Medicare cancer coverage is the Part B / Part D split. The delivery method — not the drug class — determines which bucket applies, and the two buckets carry very different cost-sharing rules:

Sources: CMS 2025 Medicare Parts A & B Premiums and Deductibles (Fact Sheet); CMS Part D benefit parameters (2026).

Why the $2,100 Part D cap changes oral chemo math in 2026

Before 2026, the old "donut hole" left patients taking expensive oral cancer drugs facing thousands of dollars in cost-sharing once their spending hit the coverage gap threshold. The 2026 Part D cap eliminates that exposure entirely.

Once your combined out-of-pocket spending on covered Part D drugs — deductible, copays, coinsurance — reaches $$2,100 in a calendar year, the plan covers 100% of your covered drug costs for the remainder of that year. For a patient whose oral cancer drug costs $10,000 per month, the cap means a maximum Part D out-of-pocket of $$2,100 — not unlimited.

A critical safety net also applies at the formulary level: CMS designates antineoplastic drugs (cancer agents) as one of six protected drug classes. Plans are required to cover all or substantially all drugs within protected classes, including most chemotherapy agents. That protection significantly reduces the risk of a cancer drug being excluded from your plan's formulary. If a drug is denied coverage, you have the right to file an exception before you need it mid-cycle.

Cancer screenings at $0: prevention before diagnosis

For the 36,369 Minnehaha County Medicare beneficiaries without a current cancer diagnosis, Medicare's preventive screening benefit is the first line of defense. All the following are available at $0 cost-sharing — no deductible, no coinsurance — under both Original Medicare and Medicare Advantage plans:

• Annual mammography — women age 40 and older; also covers one baseline mammogram between ages 35–39
• Colorectal cancer screening — colonoscopy every 10 years (every 2 years for high-risk individuals), fecal immunochemical test (FIT) annually, stool DNA test every 1–3 years
• Lung cancer screening (LDCT) — annual low-dose CT for adults age 50–77 who currently smoke or quit within the past 15 years with a 20-pack-year smoking history and no symptoms
• Cervical and vaginal cancer screening — Pap test and HPV co-test every 24 months (annually for high-risk)
• Prostate cancer screening (PSA) — annual PSA blood test for men age 50 and older

One practical caveat: if a colonoscopy finds and removes a polyp during what begins as a preventive procedure, it reclassifies from preventive to therapeutic — and cost-sharing may apply. Verify how your specific plan handles this scenario before scheduling your procedure, since rules can differ between Original Medicare and Advantage plans.

Medigap vs. Medicare Advantage for cancer patients

The stakes for getting Medicare's structure right are highest for beneficiaries managing cancer or with a significant diagnosis history. Here's how the two primary tracks compare for Part B-intensive care like IV chemotherapy and radiation:

Source: CMS — Choosing a Medigap Policy (Publication 02110); standardized per 42 CFR §403.205.

For cancer patients, Medigap Plan G's key advantage is network freedom — you can see any oncologist in the country who accepts Medicare, with no prior authorization gate and no risk of a specialist falling out of network mid-treatment. Plan N covers the same 20% coinsurance gap but adds $20 office copays and $50 ER copays, and does not cover Part B excess charges. For patients with frequent outpatient chemo visits, those copays can accumulate quickly.

The five standard Medicare Advantage PPOs in Minnehaha County offer an alternative cost structure — a network-based MOOP that caps combined annual costs:

Source: CMS Medicare Advantage / Part D Landscape (PY2026) & CMS Medicare Advantage & Part D Star Ratings (2026), Minnehaha County 2026.

Medicare Advantage PPOs are network-dependent — your cost-sharing protection applies in-network. Out-of-network care under a PPO is still available, but typically at higher cost-sharing rates. For a patient beginning or continuing a cancer treatment regimen, the non-negotiable step is confirming that your specific oncologist and the facility where you receive infusions are in the plan's 2026 network before you enroll or switch. Provider network participation changes every plan year.

The Sanford-Avera fork for cancer care

In Sioux Falls, cancer care runs through two competing health systems. Your plan's network is the bridge to them — and choosing the wrong plan could mean paying out-of-network rates for your specialist visits:

Source: CMS Hospital Compare — Overall Star Ratings.

Sanford USD Medical Center's 5-star CMS overall rating reflects top-quartile performance across multiple quality, safety, and patient-experience domains. Avera McKennan Hospital's 4-star rating is strong and well above the national median. Both systems operate dedicated cancer centers in Sioux Falls.

For plan selection purposes, the practical question is: which system does your oncologist — or the oncologist you would choose — work within? The Sanford-backed Align PPOs (ChoicePlus and ChoiceElite) are built around the Sanford network. Aetna and Wellmark's PPOs are typically accessible across both major systems. If your care requires a specialist at one system and a procedure at the other, confirm both are in-network before AEP closes December 7.

Five steps for cancer-managing Medicare beneficiaries in Sioux Falls

1. Map your chemotherapy route before plan selection. Ask your oncologist whether your current or planned drugs are IV/infused (Part B) or oral (Part D). That split determines which coverage bucket — and which protection mechanism — applies.
2. Check your Part D formulary for antineoplastic drug coverage. CMS requires plans to cover protected-class cancer drugs comprehensively — but formulary tier placement and cost-sharing still vary. Run your exact medications on Medicare.gov's Plan Finder before the October 15 AEP opens.
3. Confirm the $2,100 cap applies to your specific drug. The cap covers drugs on your plan's formulary. If a drug is denied formulary placement, file for a formulary exception as early as possible — mid-cycle is not the time to discover the gap.
4. Review your Part B exposure. If you're on Original Medicare without Medigap, calculate your potential annual Part B cost at 20% of your expected chemo and radiation billings. If the exposure exceeds the cost of Plan G premiums, Medigap deserves a hard look — though the guaranteed-issue window at age 65 is the lowest-cost entry point.
5. Verify your oncologist's network every October. Provider participation can change between plan years. The Annual Notice of Change (ANOC) covers plan-level changes, but individual provider status requires direct confirmation with your plan and your care team before December 7.

How we know all this: Big Sioux Benefits runs every article through a data desk that cross-references CDC PLACES county health data, CMS Medicare cost-sharing fact sheets, the CMS PY2026 plan landscape, CMS star ratings, and hospital quality files — built by Strategic AI Architects. All figures come from public federal datasets. This is education, not personal advice; verify your specific plan, formulary, and provider network with a licensed agent or Medicare.gov before enrolling. We do not take carrier payments to feature any plan. We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options.